GENEVA--(BUSINESS WIRE)--SpinX Technologies, a privately-held provider of innovative technology to perform bioassays in research and in clinical settings, today announced that it has expanded its Advisory Board with leading individuals from the life sciences business. The Advisory Board complements the strengths of SpinX Technologies’ existing Board of Directors, and signals that SpinX Technologies has moved from microfluidics research to the market, specifically in the field of nanoliter scale liquid handling and assay detection for diagnostics and drug development.
